Spirometry procedures are assigned the status indicator of “X” in the HOPPS. This
means that these procedures are considered ancillary services for which payment is
allowed. For payment rates and information, click on the code in the
CPT Coding/Payment Guidelines section.
* Existence of coding does not guarantee coverage or payment for any procedure by any payer. Medical necessity
for the procedure must be established by the patient's physician in accordance with specific payer guidelines.
| Low | High | Description |
| 011.00 | 011.06 | Tuberculosis of lung, infiltrative |
| 011.10 | 011.16 | Tuberculosis of lung, nodular |
| 011.20 | 011.26 | Tuberculosis of lung with cavitation |
| 011.30 | 011.36 | Tuberculosis of bronchus |
| 011.40 | 011.46 | Tuberculous fibrosis of lung |
| 011.50 | 011.56 | Tuberculous bronchiectasis |
| 011.60 | 011.66 | Tuberculous pneumonia (any form) |
| 011.70 | 011.76 | Tuberculous pnuemothorax |
| 011.80 | 011.86 | Other specified pulmonary tuberculosis |
| 011.90 | 011.96 | Pulmonary tuberculosis, unspecified |
| 012.00 | 012.06 | Tuberculous pleurisy |
| 012.10 | 012.16 | Tuberculosis of intrathoracic lymph nodes |
| 012.20 | 012.26 | Isolated thracheal or bronchial tuberculosis |
| 012.30 | 012.36 | Tuberculous laryngitis |
| 012.80 | 012.86 | Other specified respiratory tuberculosis |
| 031.0 | | Diseases due to other mycobacteria, pulmonary |
| 039.1 | | Actinomycotic infections; pulmonary |
| 045.00 | 045.03 | Acute paralytic poliomyelitis specified as bulbar |
| 079.82 | | SARS-associated coronavirus |
| 114.0 | | Primary coccidioidomycosis (pulmonary) |
| 116.0 | | Blastomycosis |
| 117.0 | | Sporotrichosis |
| 117.5 | | Cryptococcosis |
| 135 | | Saroidosis |
| 138 | | Late effects of acute poliomyelitis |
| 162.0 | | Malignant neoplasm of trachea |
| 162.2 | | Malignant neoplasm of main bronchus |
| 162.3 | | Malignant neoplasm of upper lobe, bronchus or lung |
| 162.4 | | Malignant neoplasm of middle lobe, bronchus or lung |
| 162.5 | | Malgnant neoplasm of lower lobe, bronchus or lung |
| 162.8 | | Malignant neoplasm of other parts of bronchus or lung |
| 162.9 | | Malignant neoplasm of bronchus and lung, unspecified |
| 163.0 | | Malignant neoplasm of parietal pleura |
| 163.1 | | Malignant neoplasm of visceral pleura |
| 163.8 | | Malignant neoplasm of other specified sites of pleura |
| 163.9 | | Malignant neoplasm of pleura, unspecified |
| 164.0 | | Malignant neoplasm of thymus |
| 164.1 | | Malignant neoplasm of heart |
| 164.2 | | Malignant neoplasm of anterior mediastinum |
| 164.3 | | Malignant neoplasm of posterior mediastinum |
| 164.8 | | Other malignant neoplasm |
| 164.9 | | Malignant neoplasm of mediastinum, part unspecified |
| 165.0 | | Malignant neoplasm of upper repiratory tract, part unspecified |
| 165.8 | | Malignant neoplasm of other and ill defined sites within the repiratory system and intrathoracic organs |
| 197.0 | | Secondary malignant neoplasm of lung |
| 212.3 | | Benign neoplasm of bronchus and lung |
| 212.4 | | Benign neoplasm of pleura |
| 212.5 | | Benign neoplasm of mediastinum |
| 228.1 | | Pulmonary lymphangioma, any site |
| 231.2 | | Carcinoma in situ, bronchus and lung |
| 235.7 | | Neoplasm of uncertain behavior, trachea, bronchus, and lung |
| 239.1 | | Neoplasm of unspecified nature of the respiratory system |
| 277.00 | | Cystic fibrosis; without mention of meconium ileus |
| 277.01 | | Cystic fibrosis; with meconium ileus |
| 277.02 | | Cystic fibrosis; with pulmonary manifestations |
| 277.03 | | Cystic fibrosis; with gastrointestinal manifestations |
| 277.09 | | Cystic fibrosis; with other manifestations |
| 277.81 | | Primary carnitine deficiency |
| 277.82 | | Carnitine deficiency due to inborn errors of metabolism |
| 277.83 | | latrogenic carnitine deficiency |
| 277.84 | | Other secondary carnitine deficiency |
| 277.89 | | Other specified disorders of metabolism |
| 289.0 | | Polycythemia, secondary |
| 335.20 | | Amyotrophic lateral sclerosis |
| 344.89 | | Other specified paralytic syndrome |
| 357.0 | | Acute Infective polyneuritis |
| 358.00 | | Myastheniagravis without (acute) exacerbation |
| 358.01 | | Myastheniagravis with (acute) exacerbation |
| 359.1 | | Hereditary progressive muscular dystrophy |
| 415.11 | | latrogenic pulmonary embolism and infarction |
| 415.19 | | Other pulmonary embolism and infarction |
| 416.0 | | Primary pulmonary hypertension |
| 416.1 | | Kyphoscoliotic heart disease |
| 416.8 | | Other chronic pulmonary heart diseases |
| 416.9 | | Chronic pulmonary heart disease, unspecified |
| 428.0 | | Congestive heart failure, unspecified |
| 428.1 | | Left heart failure |
| 428.20 | 428.23 | Systolic heart failure |
| 428.30 | 428.33 | Diastolic heart failure |
| 428.40 | 428.43 | Combined systolic and diastolic heart failure |
| 428.9 | | Heart failure unspecified |
| 466.0 | | Acute bronchitis |
| 466.11 | | Acute bronchiolitis due to repiratory syncytial virus (RSV) |
| 466.19 | | Acute bronchiolitis due to other infectious organisms |
| 480.3 | | Pneumonia due to SARS-associated coronavirus |
| 490 | | Bronchitis, not specified as acute or chronic |
| 491.0 | | Simple chronic bronchitis |
| 491.1 | | Mucopurulent chronic bronchitis |
| 491.20 | 491.21 | Obstructive chronic bronchitis |
| 492.0 | | Emphysematous bleb |
| 492.8 | | Other emphysema |
| 493.00 | 493.02 | Extrinsic asthma |
| 493.10 | 493.12 | Intrinsic asthma |
| 493.20 | 493.22 | Chronic obstructive asthma |
| 493.81 | | Exercise induced bronchospasm |
| 493.82 | | Cough variant asthma |
| 493.90 | 493.92 | Asthma, unspecified |
| 494.0 | | Bronchiectasis without acute exacerbation |
| 494.1 | | Bronchiectasis with acute exacerbation |
| 495.0 | 495.9 | Extrinsic allergic alveolitis |
| 496 | | Chronic airway obstruction, not elsewhere classified (COPD) |
| 500 | | Coal workers' pneumoconiosis (anthracosilicosis, anthacosis, black lung disease, miner's asthma) |
| 501 | | Asbestosis |
| 502 | | Pnuemoconiosis due to other silica or sillicates (pnuemoconiosis due to talc, silicotic fibrosis of lung, silicosis) |
| 503 | | Pneumoconiosis due to inorganic dust (aluminosis, bauxite, berylliosis, graphite fibrosis, siderosis, stannosis) |
| 504 | | Pneumonopathy due to inhalation of other dust (byssinosis, cannabinosis, flax-dressers disease) |
| 505 | | Pneumoconiosis, unspecified |
| 508.1 | | Chronic and other pulmonary manifestations due to radiation (fibrosis of lung) |
| 511.0 | | Pleurisy without mention of effusion or current tuberculosis |
| 515 | | Post inflammatory pulmonary fibrosis |
| 516.3 | | Idiopathic pulmonary fibrosis |
| 517.2 | | Lung involvement in systemic sclerosis |
| 517.8 | | Lung involvement in other diseases classified elsewhere |
| 518.0 | | Pulmonary collapse |
| 518.81 | | Acute respiratory failure |
| 518.89 | | Chronic pulmonary vascular occlusive disease |
| 519.1 | | Other diseases of trachea and bronchus, not elsewhere classified |
| 519.4 | | Disorders of diaphragm |
| 519.8 | | Other diseases of respiratory system, not elsewhere classified |
| 710.0 | | Systemic lupus erythematosus |
| 714.81 | | Rheumatoid lung |
| 737.10 | | Kyphosis (acquired) (postural) |
| 737.30 | | Scoliosis [and kyphoscoliosis], idiopathic |
| 754.2 | | Certain congenital musculoskeletal deformities of spine |
| 754.81 | | Pectus excavatum |
| 780.50 | 780.57 | Sleep disturbances |
| 782.5 | | Cyanosis |
| 786.00 | 786.09 | Dyspnea and respiratory abnormalities |
| 786.1 | | Stridor |
| 786.2 | | Cough |
| 790.91 | | Abnormal arterial blood gases |
| 793.1 | | Nonspecific abnormal findings in lung field |
| 799.0 | | Asphyxia (hypoxemia, hypoxia, pulse oximetry showing desaturation) |
| 909.5 | | Late effect of adverse effect of drug, medicinal or biological substance |
| 987.0 | 987.9 | Toxic effect of other gases, fumes, or vapors |
| 998.81 | | Emphysema (subcutaneous) (surgical) resulting from a procedure |
| V01.82 | | Exposure to SARS-associated coronavirus |
| V12.6 | | Personal history of diseases of respiratory system |
| V42.1 | | Heart transplant |
| V42.6 | | Lung transplant |